SCHEMBL10224339

SCHEMBL10224339

COC(=O)c1cc(N(C)C)c(Cl)c(S(=O)(=O)/N=C/N(C)C)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ ALDH1A1 P00352 3/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ HPGD P15428 2/20 0.35
▸ LMNA P02545 2/20 0.35
▸ GAA P10253 2/20 0.35
▸ CYP2C9 P11712 2/20 0.34
▸ ACLY P53396 3/20 0.33
▸ CA12 O43570 1/20 0.33
▸ CA1 P00915 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ CA7 P43166 1/20 0.33
▸ CA9 Q16790 1/20 0.33
▸ CA14 Q9ULX7 1/20 0.33
▸ F2 P00734 1/20 0.33
▸ PRSS1 P07477 1/20 0.33
▸ PRSS2 P07478 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL572902 0.86 KDM4E (0.38) SMN1; SMN2CYP1A2TSHRCYP2C19ALDH1A1
SCHEMBL572903 0.86 KDM4E (0.38) SMN1; SMN2CYP1A2TSHRCYP2C19ALDH1A1
SCHEMBL573293 0.83 VCAM1 (0.47) SMN1; SMN2CYP1A2TSHRCYP2C19ALDH1A1
SCHEMBL573292 0.83 VCAM1 (0.47) SMN1; SMN2CYP1A2TSHRCYP2C19ALDH1A1
SCHEMBL11542934 0.81 SMN1; SMN2 (0.56) SMN1; SMN2CYP1A2TSHRCYP2C19ALDH1A1
SCHEMBL573829 0.80 RAB9A (0.36) SMN1; SMN2TSHRALDH1A1HPGDLMNA
SCHEMBL573830 0.80 RAB9A (0.36) SMN1; SMN2TSHRALDH1A1HPGDLMNA
SCHEMBL10222902 0.80 RAB9A (0.36) SMN1; SMN2TSHRALDH1A1HPGDLMNA
SCHEMBL574330 0.79 LMNA (0.39) SMN1; SMN2CYP1A2TSHRCYP2C19ALDH1A1
SCHEMBL574329 0.79 LMNA (0.39) SMN1; SMN2CYP1A2TSHRCYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012018635-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE NEUROTHERAPEUTICS PHARMA, INC. (US) 2012-02-09 — — WO disclosed
Send feedback